Abstract
It has been reported that the concentration of free placental growth factor (PlGF) is decreased and that of soluble fms-like tyrosine kinase 1 (sFlt-1) is increased before the onset of preeclampsia. However, no study has determined the reference values for sFlt-1 and free PlGF during pregnancy using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. This longitudinal cohort study was undertaken to address this issue. Serum samples were collected from 148 women at 10, 18, 28, and 37 weeks of gestation. Preeclampsia occurred in 6 women: 4 women who delivered at <37 weeks of gestation, and 2 women who delivered at ≥37 weeks. The average and 90% confidence interval (90% CI) of the serum concentration of both sFlt-1 and free PlGF were determined in a total of 433 specimens from 148 subjects with 1 to 4 collections at 7 to 39 weeks of gestation, and were represented as quadric curves. The mean values (90% CI) of sFlt-1 (pg/ml) at 10, 18, 28, and 37 weeks of gestation were 413 (174–981), 296 (125–704), 413 (174–982), and 1,130 (477–2,690), respectively. The mean values (90% CI) of free PlGF (pg/ml) were 36 (14–89), 206 (83–515), 518 (207–1,290), and 354 (142–884), respectively. We also established the reference values for the ratio of sFlt-1/PlGF. These values may be useful for predicting the subsequent occurrence of preeclampsia.
Similar content being viewed by others
Article PDF
References
Yum MK, Kim K, Kim JH, Park EY : A consistent abnormality in the average local smoothness of fetal heart rate in growth-restricted fetuses affected by severe pre-eclampsia. Hypertens Res 2004; 27: 911–918.
Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T : Association study using single nucleotide polymorphisms in the estrogen receptor beta (ESR2) gene for preeclampsia. Hypertens Res 2004; 27: 903–909.
Campbell S : Parallel universes. Ultrasound Obstet Gynecol 2004; 24: 701–703.
Khong TY, De Wolf F, Robertson WB, Brosens I : Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–1059.
Lin S, Shimizu I, Suehara N, Nakayama M, Aono T : Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760–765.
Maynard SE, Min JY, Merchan J, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649–658.
Levine RJ, Maynard SE, Qian C, et al: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683.
Ikeda Y, Fukuda N, Wada M, et al: Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res 2004; 27: 119–128.
Imanishi T, Hano T, Nishio I : Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004; 27: 101–108.
Uruno A, Sugawara A, Kanatsuka H, et al: Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells. Hypertens Res 2004; 27: 887–895.
Sata M, Hirata Y, Nagai R : Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Hypertens Res 2002; 25: 577–582.
Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ : Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179: 1539–1544.
Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA : Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177–182.
Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS : Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267–1272.
Chappell LC, Seed PT, Briley A, et al: A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127–136.
Livingston JC, Haddad B, Gorski LA, et al: Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 184: 1218–1220.
Thadhani R, Mutter WP, Wolf M, et al: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770–775.
Stepan H, Geide A, Faber R : Soluble fms-like tyrosine kinase 1. N Engl J Med 2004; 351: 2241–2242.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirashima, C., Ohkuchi, A., Arai, F. et al. Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant Women. Hypertens Res 28, 727–732 (2005). https://doi.org/10.1291/hypres.28.727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.727
Keywords
This article is cited by
-
Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome
Archives of Gynecology and Obstetrics (2019)
-
Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia: a systematic review and meta-analysis
Archives of Gynecology and Obstetrics (2017)
-
Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy
Journal of Human Hypertension (2016)
-
A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients
The Journal of Obstetrics and Gynecology of India (2016)
-
Plasma level of hydroxysteroid (17-β) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio
Hypertension Research (2012)